overdosing on semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Ozempic May Decrease Opioid Overdose
Description
The FDA recently approved oral Wegovy (25mg semaglutide) as the first oral GLP-1 pill specifically approved for weight loss, launching in early 2026
This condition shows up about three months after treatment begins
Footnotes Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity FDA.gov
Medical experts suggest these tips: Keep unopened pens in a fridge set between 36F and 46F
